COMPARISON OF 4 IMMUNOSEROLOGIC ASSAYS FOR DETECTION OF ANTIBODIES TO BORRELIA-BURGDORFERI IN PATIENTS WITH CULTURE-POSITIVE ERYTHEMA MIGRANS

被引:27
作者
MITCHELL, PD [1 ]
REED, KD [1 ]
ASPESLET, TL [1 ]
VANDERMAUSE, MF [1 ]
MELSKI, JW [1 ]
机构
[1] MARSHFIELD CLIN FDN MED RES & EDUC, DEPT DERMATOL, MARSHFIELD, WI 54449 USA
关键词
D O I
10.1128/JCM.32.8.1958-1962.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In view of the significant sequelae associated with Lyme borreliosis, there is a need for timely and accurate diagnosis of erythema migrans (EM). Although Borrelia burgdorferi can be cultured from biopsies of EM lesions, immunodiagnostic testing is more widely available. Four immunoserologic methods were studied by using the sera of 51 patients with EM lesions that were culture positive for B. burgdorferi. Nineteen patients had single primary lesions, and thirty-two had multiple secondary lesions. At the time of biopsy, 40 patients, 8 with primary lesions and all patients with secondary lesions, were seropositive by an immunoglobulin M (IgM) indirect fluorescent-antibody (IgM IFA) test (Bion Enterprises). Twenty-three patients were seropositive by a whole-cell fluorescence enzyme immunoassay (EIA) (BioWhittaker, Inc.), twenty-two were positive by immunoblotting (ViroStat, Inc.), and one was positive by a P39 recombinant EIA (P39 EIA) (General Biometrics, Inc.). Sera from various patient control groups were tested: rheumatoid arthritis (n = 19), infectious mononucleosis (n = 20), systemic lupus (n = 22), syphilis (n = 13), streptococcal sequelae (n = 20), and healthy subjects (n = 16). None of these sera reacted with the IgM IPA test or P39 EIA. Fifteen reacted with the fluorescence EIA. We conclude that the IgM IFA test is an effective and reliable assay for the diagnosis of EM, particularly for patients with secondary lesions. Immunoblot, fluorescence EIA, and P39 EIA lack the sensitivity to reliably diagnose EM.
引用
收藏
页码:1958 / 1962
页数:5
相关论文
共 55 条
[1]   SERODIAGNOSIS IN EARLY LYME-DISEASE [J].
AGUEROROSENFELD, ME ;
NOWAKOWSKI, J ;
MCKENNA, DF ;
CARBONARO, CA ;
WORMSER, GP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (12) :3090-3095
[2]  
ASBRINK E, 1991, SCAND J INFECT DIS, P44
[3]  
Bakken L., 1991, Clinical Immunology Newsletter, V11, P186, DOI 10.1016/0197-1859(91)90020-S
[4]   PERFORMANCE OF 45 LABORATORIES PARTICIPATING IN A PROFICIENCY TESTING PROGRAM FOR LYME-DISEASE SEROLOGY [J].
BAKKEN, LL ;
CASE, KL ;
CALLISTER, SM ;
BOURDEAU, NJ ;
SCHELL, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07) :891-895
[5]  
BARBOUR A G, 1988, Clinical Microbiology Reviews, V1, P399
[6]   SERODIAGNOSIS OF EARLY LYME-DISEASE - ANALYSIS OF IGM AND IGG ANTIBODY-RESPONSES BY USING AN ANTIBODY-CAPTURE ENZYME-IMMUNOASSAY [J].
BERARDI, VP ;
WEEKS, KE ;
STEERE, AC .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04) :754-760
[7]  
BERGER BW, 1989, REV INFECT DIS, V11, pS1475
[8]   LYME-DISEASE [J].
BERGER, BW ;
LESSER, RL .
DERMATOLOGIC CLINICS, 1992, 10 (04) :763-775
[9]   CULTIVATION OF BORRELIA-BURGDORFERI FROM ERYTHEMA MIGRANS LESIONS AND PERILESIONAL SKIN [J].
BERGER, BW ;
JOHNSON, RC ;
KODNER, C ;
COLEMAN, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (02) :359-361
[10]   ISOLATION AND CHARACTERIZATION OF THE LYME-DISEASE SPIROCHETE FROM THE SKIN OF PATIENTS WITH ERYTHEMA CHRONICUM MIGRANS [J].
BERGER, BW ;
KAPLAN, MH ;
ROTHENBERG, IR ;
BARBOUR, AG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 13 (03) :444-449